MENU
+Compare
VRBCF
Stock ticker: OTC
AS OF
May 22 closing price
Price
$346.00
Change
+$22.00 (+6.79%)
Capitalization
3.09B

VRBCF stock forecast, quote, news & analysis

Virbac SA is a drug manufacturing company with a focus on animal health... Show more

A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
published Dividends

VRBCF paid dividends on June 25, 2021

Virbac SA VRBCF Stock Dividends
А dividend of $0.75 per share was paid with a record date of June 25, 2021, and an ex-dividend date of June 23, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 88.9B. The market cap for tickers in the group ranges from 72.83K to 685.53B. LLY holds the highest valuation in this group at 685.53B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 11%. MDCX experienced the highest price growth at 20%, while JCRRF experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -77%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 31
P/E Growth Rating: 69
Price Growth Rating: 54
SMR Rating: 61
Profit Risk Rating: 80
Seasonality Score: -36 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
2065m LID
Phone
N/A
Employees
5386
Web
https://www.virbac.com